Published in Cancer Weekly, April 10th, 1995
The most widely used test currently available is the combination of prostate specific antigen (PSA) and a digital rectal exam (DRE), which has a positive predictive value of only 48.5 percent in men over age 50.
Clinical experts in this field, such as Thomas A. Stamey, M.D. of the Department of Urology, Stanford University School of Medicine, agree that testing for prostate cancer should be done annually, as recommended by the American...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.